Hairy Cell Leukemia: Residual Splenic Disease After Successful α_2b-Interferon Therapy

References

• Golomb H. M., Catovsky D., Golde D. W. Hairy cell fluctuations. A clinical review based on 71 cases. Ann. Intern. Med 1978; 89: 677–689
   PubMed Web of Science ®Google Scholar
• Jansen J., Hermans J., Remme J., Den Ottolander G. J., Lopes-Gardozo P. Hairy cell leukemia. Clinical features and effect of splenectomy. Scand. J. Haematol 1978; 21: 60–71
   PubMedGoogle Scholar
• Schafer A. L., Rosenthal D. S., Moloney W. C. Hairy cell leukemia: diagnosis and management. Am. J. Med 1978; 275: 297–308
   Web of Science ®Google Scholar
• Mintz U., Golomb H. M. Splenectomy as initial therapy in twenty-six patients with leukemia reticuloendotheliosis (Hairy cell leukemia). Cancer Res 1979; 39: 2366–2370
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A. Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 1979; 53: 412–436
   PubMed Web of Science ®Google Scholar
• Jansen J., Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 1981; 47: 2066–2076
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Catovsky D., Golde D. W. Hairy cell leukemia; a five year update on seventy-one patients. Ann. Intern. Med 1983; 99: 485–486
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Vardiman J. W. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 1983; 61: 349–352
   PubMed Web of Science ®Google Scholar
• Damasio E. E., Spriano M., Repetto M., Vimercati A. R., Rossi E., Occhini D., Marmont A. M. Hairy cell leukemia: a retrospective study of 235 cases by the Italian Cooperative Group (ICGHCL) according to Jansen's clinical staging system. Acta. Haematol 1984; 72: 326–334
   PubMed Web of Science ®Google Scholar
• Flandrin G., Sigaux F., Sebahoun G., Bouffette P. Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin. Oncol 1984; 11: 458–471
   PubMed Web of Science ®Google Scholar
• Van Norman A. S., Nagorney D. M., Martin J. K., Phyliky R. L., Illstrup D. M. Splenectomy for hairy cell leukemia. A clinical review of 63 patients. Cancer 1986; 57: 644–648
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Vardiman J. W., Barker C. M., Golomb H. M. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer 1988; 62: 2420–2424
   PubMed Web of Science ®Google Scholar
• Manes J. L., Blair O. M. Disseminated mycobacterium kansasii infection complicating hairy cell leukemia. JAMA 1976; 236: 1878–1879
   PubMed Web of Science ®Google Scholar
• Bouza E., Burgoleta C., Golde D. W. Infections in hairy cell leukemia. Blood 1978; 51: 851–859
   PubMed Web of Science ®Google Scholar
• Weinstein R. A., Gelmann E., Golomb H. M. Disseminated atypical mycobacterial infection in hairy cell leukaemia. Lancet 1978; 2: 1052–1053
   PubMed Web of Science ®Google Scholar
• Stewart D. J., Bodey G. P. Infections in hairy cell leukemia (leukemic reticuloendotheliosis). Cancer 1981; 47: 801–805
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Hersh E. M., Manning J., Reuben J., Keating M., Schnipper E., Itri L., Gutterman J. U. Treatment of hairy cell leukemia with recombinant alphainterferon. Blood 1986; 68: 493–497
   PubMed Web of Science ®Google Scholar
• Ehmann W. C., Silber R. Recombinant alpha-2-interferon for interferon for treatment of hairy cell leukemia without prior splenectomy. Am. J. Med 1986; 80: 1111–1114
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Vardiman J. W., Golomb H. M. The role of interferon in the treatment of hairy cell leukemia. Semin. Oncol 1986; 13: 21–28, (Suppl)
   PubMed Web of Science ®Google Scholar
• Bardawil R. G., Ratain M. J., Golomb H. M., Bitter M. A., Groves C., Vardiman J. W. Changes in peripheral blood and bone marrow specimens during and after α2b-interferon therapy for hairy cell leukemia. Leukemia 1987; 1: 340–343
   PubMed Web of Science ®Google Scholar
• Flandrin G., Castaigne S., Sigaux F., Degos L. Results of treating 53 hairy cell leukemia patients with α-interferon. Leukemia 1987; 1: 326–328
   PubMed Web of Science ®Google Scholar
• Pangalis G. A., Kittas Ch., Viniou N., Kokkinou S., Variamis H., Paizis P., Melanthiou F., Fessas Ph. Hairy cell leukemia: Bone marrow changes following splenectomy and α-interferon therapy. Leukemia 1987; 1: 343–346
   PubMed Web of Science ®Google Scholar
• Pralle H., Zwingers Th., Boedewadt S., Bross K., Dorken B., Gamm H., Ho A. D., Parwaresch R. M., Schmitz N., Papendick U., Asshoff D., Bremer K., Euler H., Fischer Th., Gasner A., Goldmann A., Hartlapp J., Hayungs J., Heinen U., Heyll A., Kraft J., Lohmeyer J., Meier P., Neubauer A., Nowicki L., Pfluger K., Sab R., Schmidt W., Schuster D., Straif K., Westerhausen M. A prospective multicenter trial with human recombinant α2c-interferon in hairy cell leukemia before and after splenectomy. Leukemia 1987; 1: 337–340
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Ratain M. J., Fefer A., Thompson J., Golde D. W., Ozer H., Portlock C., Silber R., Rappeport J., Bonnem E., Spiegel R., Tensen L., Burke J. S., Vardiman J. W. Randomized study of the duration of treatment with interferon alpha-2b in patients with hairy cell fluctuations. J. Natl. Cancer Inst 1988; 80: 369–378
   PubMed Web of Science ®Google Scholar
• Hoffman V., Frey B. Long term treatment of hairy cell leukemia with interferon alpha-2b. Cancer Treat Rev 1988; 15: 7–13, (Suppl)
   PubMed Web of Science ®Google Scholar
• Catovsky D., Quesada J. R., Golomb H. M. Proposed criteria for evaluation of response to treatment in hairy cell leukemia. Leukemia 1987; 1: 405–406
   PubMed Web of Science ®Google Scholar
• Pangalis G. A. Contribution of cytochemistry in leukemia. A Polliack Human Leukemias Cytochemical and ultrastructural techniques in diagnosis and research. Martinus Nijhoff, The Hague, Boston, London 1984; 3–14
   Google Scholar
• Yam L. T., Janckila A. J., Li C. Y., Lma W. K. W. Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience. Leukemia 1987; 1: 285–288
   PubMed Web of Science ®Google Scholar
• Stein H., Gatter K., Asbahr H., Mason D. Y. Use of freeze-dried paraffin embedded sections for immunohistologic staining with monoclonal antibodies. Lab. Invest 1985; 52: 676–683
   PubMed Web of Science ®Google Scholar
• Cordell J. L., Falini B., Erber W. N., Erber W. N., Ghosh A., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J. Histochem. Cytochem 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Burke J. S., Byrne G. E., Jr., Rappaport H. Hairy cell leukemia (leukemic reticuloendotheliosis). I. A clinical pathologic study of 21 patients. Cancer 1974; 33: 1399–1410
   PubMed Web of Science ®Google Scholar
• Vykoupil K. F., Thiele J., Georgii A. Hairy cell leukemia. Bone marrow findings in 24 patients. Virch. Arch., A. Path. Anat, and Histol 1976; 370: 273–289
   PubMed Web of Science ®Google Scholar
• Burke J. S. The value of the bone marrow biopsy in the diagnosis of hairy cell leukemia. Am. J. Clin. Pathol 1978; 70: 876–884
   PubMed Web of Science ®Google Scholar
• Bartl R., Frisch B., Hill W., Burkhardt R., Sommerfeld W., Sund M. Bone marrow histology in hairy cell leukemia. Identification of subtypes and their diagnostic significance. Am. J. Clin. Pathol 1983; 79: 531–545
   PubMed Web of Science ®Google Scholar
• Goldstein A. M., Marcon L., Cullen B. R., Nelson D. L. A competitive enzyme linked immunoassay (ELISA) for the measurement of soluble human interleukin-2 receptors (IL-2R, Tac protein). J. Immunol. Methods 1988; 107: 103–109
   PubMed Web of Science ®Google Scholar
• Armitage P. Statistical methods in medical research. Oxford, Blackwell 1971
   Google Scholar
• Diebold J., Chomette G., Reynes M., Tricot G. The spleen in hairy cell leukemia. Virch. Archiv. (Pathol. Anat.) 1977; 372: 325–336
   PubMed Web of Science ®Google Scholar
• Nanba K., Soban E. J., Bowling M. C., Berard C. W. Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. Am. J. Clin. Pathol 1977; 67: 415–426
   PubMed Web of Science ®Google Scholar
• Roguet M. L., Zafrani E. S., Farcet J. P., Reyes F., Pinaudeau Y. Histopathological lesions of the liver in the hairy cell: a report of 14 cases. Hematology 1985; 5: 496–500
   Google Scholar
• Burke J. S., Sheibani K., Winberg C. D., Rappaport H. Single case reports. Recognition of hairy cell fluctuations in a spleen of normal weight. The contribution of immunohistologic studies. Am. J. Clin. Pathol 1987; 87: 276–281
   PubMed Web of Science ®Google Scholar
• Katayama I. Bone marrow in hairy cell leukemia. Hematol. Oncol. Clin. North America 1988; 2: 585–602
   PubMed Web of Science ®Google Scholar
• Berman E., Posnett D. N. Diagnosis and monitoring in patients with hairy cell leukemia using the monoclonal antibody Anti-HC2. Leukemia 1987; 1: 305–307
   PubMed Web of Science ®Google Scholar
• Porzsolt F. Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy. Blut 1986; 52: 265–272
   PubMedGoogle Scholar
• Damasio E. E., Federico M., Frassoldati A. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative group for HCL. Preliminary results. Eur. J. Haematol 1990; 45: 29–31, Suppl. 52
   Web of Science ®Google Scholar
• Myers T. J., Ikeda Y., Schwartz S., Pharmakidis A. B., Baldini M. G. Primary splenic hairy cell leukemia-remission for 21 years following splenectomy. Am. J. Haematol 1981; 11: 299–303
   PubMed Web of Science ®Google Scholar
• Steis R. G., Marcon L., Clark J., Urba W., Long D. L., Nelson D. L., Maluish A. E. Serum soluble IL-2 receptors as a tumor marker in patients with hairy cell leukemia. Blood 1988; 71: 1304–1309
   PubMed Web of Science ®Google Scholar